Neurocrine Biosciences
NBIX
126 hedge funds and large institutions have $778M invested in Neurocrine Biosciences in 2013 Q2 according to their latest regulatory filings, with 126 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
86.72% more ownership
Funds ownership: 0% → 86.72% (+87%)
45% more call options, than puts
Call options by funds: $14.3M | Put options by funds: $9.9M
Top Buyers
Top Sellers
NBIX Hedge Fund Activity: Q2 2013 in Review
126 of the 3,075 institutional investors tracked by Wall St. Rank reported a position in Neurocrine Biosciences (NBIX) for Q2 2013, worth a combined $778M.
Buyers outnumbered sellers: 126 funds opened new NBIX positions and 0 closed out — a net gain of 126 holders — while 0 added to existing stakes and 0 trimmed.
- 126 institutional investors held Neurocrine Biosciences (NBIX) as of Q2 2013, up from 0 in Q1 2013.
- Funds reported $778M of Neurocrine Biosciences stock for Q2 2013.
- 126 funds opened new Neurocrine Biosciences positions in Q2 2013 and 0 closed out, a net change of +126 holders.
Based on aggregated 13F filings for Q2 2013.